Trial intelligence / Profile preview

Tadalafil for endothelial function in men with erectile dysfunction

ChiCTR-TRC-11002109Phase 4Recruiting

Sponsor
The First Affiliated Hospital of Wenzhou Medical University
Start
Jul 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of tadalafil in erectile dysfunction (ED) (3 arms), sponsored by The First Affiliated Hospital of Wenzhou Medical University. Primary endpoints: Thromboxane B2, Endothelial progenitor cells and 7 more. Started Jul 2012; status: recruiting.

02

Drugs

tadalafil
03

Conditions

erectile dysfunction (ED)

Beyond the preview

Go deeper on ChiCTR-TRC-11002109.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-11002109.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call